Cecilia M Roteli-Martins

Author PubWeight™ 17.14^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.	Lancet	2004	8.09
2	Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.	Lancet	2006	7.83
3	Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.	Hum Vaccin Immunother	2014	1.48
4	Whole, Turret and step methods of rapid rescreening: is there any difference in performance?	Diagn Cytopathol	2007	0.75